Solésence, Inc. — Form 8-K Summary
Reporting context: The company filed this 8-K on October 2, 2026, regarding a Nasdaq notice received September 29, 2026. The filing reports a listing-compliance matter, not quarterly or annual financial results.
Key event
Nasdaq notified Solésence that its common stock had closed below the $1.00 minimum bid price for 30 consecutive trading days, violating Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the stock’s Nasdaq Capital Market listing or the company’s SEC reporting obligations.
- Initial compliance deadline: March 29, 2027, a 180-calendar-day period.
- To regain compliance: The closing bid price must be at least $1.00 for a minimum of 10 consecutive trading days before the deadline.
- Possible additional period: Solésence may qualify for an additional 180 days if it meets applicable listing standards other than the bid-price requirement and notifies Nasdaq of its intent to cure the deficiency. The filing says Nasdaq staff would be expected to grant the extension if requirements are met.
Financial metrics and comparison
This 8-K provides no revenue, profit, cash flow, margin, debt, or liquidity figures and no financial-period comparison. It does not state the current share price or quantify the financial impact of the listing deficiency.
Outlook, risks, and contingencies
The company says it is evaluating courses of action to regain compliance but gives no specific plan. It cautions that there is no assurance it will cure the deficiency, obtain an extension, or remain compliant with other Nasdaq requirements. Noncompliance or delisting could materially and adversely affect its ability to raise capital, financial condition, and business. The company also cites potential costs and diversion of personnel and resources.
Investor facts to verify
- Whether Solésence’s closing bid price reaches at least $1.00 for 10 consecutive trading days by March 29, 2027.
- Whether Nasdaq grants an additional compliance period and whether the company meets its eligibility requirements.
- Whether the company maintains compliance with other Nasdaq listing standards and what actions, if any, it takes to address the deficiency.
- Any subsequent company filings describing the effects on financing, operations, or financial condition.